VY
Vycor Medical, Inc.
VYCO · OTC
$0.07 +0.00% (+$0.00)
1M -5.58%
Market Cap $2.20M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.07
4.5% upside
Current Price
$0.067
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VYCO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
29 /100
Expensive P/S 1.22x
P/FCF 36.85x
EV/EBITDA 59.10x
Growth
88 /100
Growing Rev. growth 15.07%
FCF growth N/A
Book val. growth N/A
Profitability
31 /100
Weak Net margin 3.32%
Op. margin 2.67%
FCF margin 3.31%
Quality
21 /100
Poor ROA 7.37%
Asset turnover 2.22x
ROIC 1.82%
Debt
1 /100
High Int. coverage 0.41x
Net debt/EBITDA 20.37x
Current ratio 0.13x
Stability
43 /100
Moderate Rev. volatility 5.61%
EPS volatility 176.27%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VYCO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Peter C. Zachariou
Employees
7
Headquarters
Boca Raton